SCHEMBL5768400

SCHEMBL5768400

CCCCOC(=O)N1CCC(N[C@@H](C)c2ccccc2)C(C(=O)OC)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 7/20 0.43
POLB P06746 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
ALDH1A1 P00352 1/20 0.39
P2RY12 Q9H244 2/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5770204 0.85 CTSK (0.44) CTSKPOLBNPC1RAB9ASMN1; SMN2
SCHEMBL1219526 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL12896154 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL1220239 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL13038043 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL12884069 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL1221071 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL1219529 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL14393674 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4
SCHEMBL12884095 0.82 GPR119 (0.47) NPC1RAB9AALDH1A1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1656345-A1 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Company (US) 2006-05-17 EP disclosed
WO-2005021500-A1 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2005-03-10 WO disclosed